ANCA-associated vasculitis—clinical utility of using ANCA specificity to classify patients

D Cornec, ECL Gall, FC Fervenza… - Nature Reviews …, 2016 - nature.com
The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are a
heterogeneous group of rare syndromes characterized by necrotizing inflammation of small …

Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management

G Trivioli, A Marquez, D Martorana, M Tesi… - Nature Reviews …, 2022 - nature.com
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises
granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic …

Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis

BF Collins, G Raghu - European Respiratory Review, 2019 - Eur Respiratory Soc
Two antifibrotic medications (nintedanib and pirfenidone) were recommended
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …

Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand: a position statement from the Thoracic …

AS Jee, R Sheehy, P Hopkins, TJ Corte… - …, 2021 - Wiley Online Library
Pulmonary complications in CTD are common and can involve the interstitium, airways,
pleura and pulmonary vasculature. ILD can occur in all CTD (CTD‐ILD), and may vary from …

Interstital lung disease in ANCA vasculitis

MA Alba, LF Flores-Suárez, AG Henderson, H Xiao… - Autoimmunity …, 2017 - Elsevier
Anti-neutrophil cytoplasmic antibodies (ANCA) vasculitides are immune-mediated disorders
that primarily affect small blood vessels of the airway and kidneys. Lung involvement, one of …

Interstitial lung disease and other pulmonary manifestations in connective tissue diseases

I Mira-Avendano, A Abril, CD Burger, PF Dellaripa… - Mayo Clinic …, 2019 - Elsevier
Lung involvement in connective tissue diseases is associated with substantial morbidity and
mortality, most commonly in the form of interstitial lung disease, and can occur in any of …

Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)

V Cottin, E Bel, P Bottero, K Dalhoff… - European …, 2016 - Eur Respiratory Soc
The respiratory manifestations of eosinophilic granulomatosis with polyangiitis (EGPA) have
not been studied in detail. In this retrospective multicentre study, EGPA was defined by …

Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort

JH Schirmer, MN Wright, R Vonthein… - …, 2016 - academic.oup.com
Objective. To evaluate the clinical presentation and long-term outcome of a vasculitis centre
cohort of patients with microscopic polyangiitis (MPA) with respect to organ manifestations …

Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis

M Sebastiani, A Manfredi, C Vacchi… - Clinical and …, 2020 - iris.unimore.it
Antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) is a group of
systemic vasculitides that predominantly affect small vessels, including granulomatosis with …

Lung involvement in ANCA-associated vasculitis

G Sacoto, S Boukhlal, U Specks, LF Flores-Suárez… - La Presse Médicale, 2020 - Elsevier
Lung involvement is one of the most common clinical features in ANCA-associated
vasculitides (AAV), including granulomatosis with polyangiitis (GPA), microscopic …